(Q73257269)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9114999%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9114999%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

main subject

myocardial infarction

1 reference

P J Schwingl

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9114999%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J Shelton

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9114999%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 March 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9114999%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9114999%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9114999%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9114999%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

125-129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9114999%20AND%20SRC:MED&resulttype=core&format=json

Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900026-7

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900026-7

Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900026-7

Risk of acute myocardial infarction and low-dose combined oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900026-7

The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900026-7

Oral contraceptives and thrombotic diseases: impact of new epidemiological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900026-7

Is oral contraceptive use still associated with an increased risk of fatal myocardial infarction? Report of a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900026-7

Risk factors for fatal venous thromboembolism in young women: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900026-7

Third generation oral contraception and venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900026-7

Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900026-7

Clinical pharmacokinetics of contraceptive steroids. An update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900026-7

Oral contraceptives and cardiovascular disease (first of two parts).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900026-7

Thrombosis with low-estrogen oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900026-7

Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900026-7

Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900026-7

Oral contraceptive use and venous thromboembolism: absence of an effect of smoking.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900026-7

Oral contraceptives, smoking, and other factors in relation to risk of venous thromboembolic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900026-7

10.1016/S0010-7824(97)00026-7

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9114999%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference